Search Results
Found 1 results
510(k) Data Aggregation
(296 days)
The CLIRANS® T-Series Hollow Fiber Dialyzers are devices used as part of an artificial kidney system for the treatment of patients with renal failure or toxemic conditions and that consists of an extracorporeal blood system, a conventional dialyzer, a dialysate delivery system, and accessories. This device is indicated for single and multiple use.
The CLIRANS® T-Series Hollow Fiber Dialyzers consists of cellulose hollow fibers with 9μ wall thickness. Blood is pumped via a roller pump from the artery of the patient into the arterial end of the dialyzer. The blood travels down through the dialyzer fibers waste products pass through the membrane of the dialysate, which is constantly circulating through the dialyzer on the outside of the hollow fibers. Blood then exits the venous end of the dialyzer back to the patient.
The CLIRANS® T-Series Hollow Fiber Dialyzers demonstrate substantial equivalence in performance to the predicate device, the CLIRANS® TAF Hollow Fiber Dialyzer (CL*M151L). The performance criteria are focused on the device's ability to clear various substances from the blood and its ultrafiltration rate.
1. Table of Acceptance Criteria and Reported Device Performance
Performance Metric | Acceptance Criteria (relative to predicate CL*M151L) | Reported Device Performance (CLIRANS® T-Series) |
---|---|---|
Urea Clearance | Substantially Equivalent | "somewhat higher clearance" than M151L |
Creatinine Clearance | Substantially Equivalent | "somewhat higher clearance" than M151L |
Phosphates Clearance | Substantially Equivalent | "somewhat higher clearance" than M151L |
Vitamin B12 Clearance | Substantially Equivalent | "somewhat higher clearance" than M151L |
UFR (In Vitro & In Vivo) | Substantially Equivalent | "somewhat higher...UFR" than M151L |
Priming Volume | Substantially Equivalent | Values (101ml, 120ml, 148ml for T-Series models) are similar to M151L (115ml) |
Study that Proves the Device Meets the Acceptance Criteria:
The device's performance was evaluated through a comparative study against the predicate device, the CLIRANS® TAF Hollow Fiber Dialyzer (CL*M151L), cleared under 510(k) K854280. The study focused on demonstrating "substantial equivalence" rather than absolute performance thresholds.
Noteworthy findings: The T-Series dialyzers exhibited "somewhat higher clearance and UFR" compared to the M151L, which the submission states is "to be expected with the thinner fiber walls in the T-Series dialyzer." Importantly, the document concludes that "none of the data raises any issues of safety or effectiveness," thus supporting the claim of substantial equivalence.
2. Sample Size Used for the Test Set and Data Provenance:
The document does not explicitly state the sample size used for the performance tests (e.g., number of dialyzers tested for each metric). The provenance of the data (e.g., country of origin, retrospective or prospective) is also not specified. These are likely in-house laboratory tests.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
This information is not applicable. The study is a laboratory-based comparative performance test of physical devices, not an assessment requiring expert interpretation of clinical data or images.
4. Adjudication Method for the Test Set:
This information is not applicable, as the tests were performance measurements of the device itself, not clinical outcomes requiring adjudication.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size:
No, an MRMC comparative effectiveness study was not done. This type of study is typically for evaluating the impact of an AI system on human clinical interpretation, which is not relevant for this device.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:
Not applicable. This device is a physical medical device (a dialyzer), not a software algorithm or AI system. Its "performance" refers to its physical characteristics and capabilities in a dialysis system.
7. The Type of Ground Truth Used:
The "ground truth" for this study is the established performance characteristics of the legally marketed predicate device, the CLIRANS® TAF Hollow Fiber Dialyzer (CL*M151L). The performance metrics (clearance for various substances, UFR, priming volume) of the new device were compared directly against those of the predicate device to establish substantial equivalence.
8. The Sample Size for the Training Set:
Not applicable. This device is a physical medical device, not a machine learning model that requires a training set.
9. How the Ground Truth for the Training Set Was Established:
Not applicable, as this is not a machine learning device.
Ask a specific question about this device
Page 1 of 1